Searched for
USFDA APPROVED FORMULATIONS
Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 crSpecialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with a...- Dr Reddy's Srikakulam unit classified as voluntary action indicated by USFDADr Reddy's Laboratories has received a report from the US Food and Drug Administration. The report concerns its manufacturing facility in S...
- Zydus Lifesciences gets USFDA nod for generic medicationZydus Lifesciences has received approval from the USFDA to market Amantadine extended-release capsules (68.5 mg) and tentative approval for...
- Sun Pharma gets USFDA nod for drug to treat neonatal seizures"With this approval, SEZABY becomes the first and only product specifically indicated in the US for the treatment of neonatal seizures in t...
- Strides Pharma drops 3% on USFDA observation for Bengaluru plantThe observations are not material in nature, the company said.
- Zydus Cadila gets USFDA nod for blood pressure drugWith the latest approvals from the USFDA, the group now has more than 140 approvals and has so far filed over 300 abbreviated new drug appl...
- Sun Pharma tanks 3% on surprise USFDA visit to Dadra plantThe stock fell 2.69% to hit a low of Rs 668 on BSE.
- Cadila gets USFDA nod to sell generic anti-viral drugCadila Healthcare has received approval from the US health regulator USFDA to market anti-viral generic Acyclovir capsules in the American ...
- Alkem's Mandva plant gets establishment nod from USFDAAlkem Labs Ltd today said one of its manufacturing plants in Gujarat has obtained the Establishment Inspection Report (EIR) "approval" from...
- Aurobindo Pharma gets USFDA nod for generic of Pfizer's RevatioAurobindo Pharma received approval from the USFDA to manufacture and market generic version of Pfizer's Revatio tablets used in the treatme...
- USFDA denies approval for SPARC's anti-glaucoma eyedropSun Pharma Advanced Research Company (SPARC) today said the US health regulator has not approved its new drug application for anti-glaucoma...
- Cipla gets USFDA nod for Lopinavir, Ritonavir oral pelletsCipla has received approval from US health regulator USFDA for Lopinavir and Ritonavir oral pellets used for treating AIDS in infants and y...
- Orchid Chemicals oral formulations plant gets USFDA approvalOrchid Chemicals & Pharmaceuticals today said US health regulator has inspected and accepted its oral formulations facility near Chennai.
- Aurobindo Pharma may get USFDA nod for new facility: SourcesAurobindo Pharma seems all set to get approval from the USFDA for its new Hyderabad-based Unit IV facility, say sources.
- Wockhardt to launch tablets treating infections in USPharmaceutical firm Wockhardt on Tuesday said it will shortly launch Azithromycin tablets, which are used for treating different kinds of i...
- USV's Daman facility gets FDA approvalUSV Limited says its solid formulations facility at Daman has received US FDA approval.
- Glenmark gets USFDA nod for Terbinafine tabsGlenmark Pharmaceuticals says it has received tentative approval from USFDA for Terbinafine HCL tablets.
- Wockhardt gets US nod for Cefprozil tabsPharma company Wockhardt Ltd on Wednesday said it has received US Food and Drug Administration (USFDA) approval for Cefprozil tablets, an a...
- Lupin set to widen its base in paediatric mktPharmaceutical firm Lupin on Thursday said it has received US Food and Drug Administration (USFDA) approval for Suprax Cefixime, an antibio...
- Wockhardt gets nod for new drugWockhardt Ltd has received tentative approval from the USFDA for anti-epileptic drug, Divalproex Sodium delayed-release tablets.
Load More
